Valuation Models on Early Stage Biotechnology and Pharmaceutical Investment
碩士 === 國立中興大學 === 科技管理研究所 === 92 === This thesis theoretically rigorous integrates capital budgeting approaches allowing pharmaceutical investment evaluation to handle uncertainty of future cash flows and future decisions. In particular, it applies the insights and techniques of Net Present Value (N...
Main Authors: | Chih-Chieh Lin, 林志傑 |
---|---|
Other Authors: | Risharng Chiang |
Format: | Others |
Language: | zh-TW |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/35010056747193291086 |
Similar Items
-
Investment & Valuation Considerations of Biotechnology Companies
by: YEH, Erh-Yang (Eric), et al.
Published: (2002) -
Economic Valuation on Applying Biotechnology to the Ganoderma Health Food
by: Miao Juan Lin, et al.
Published: (2003) -
What is the value of growth companies? A methodical approach to the valuation of growth companies in the biotechnology and pharmaceutical sector
by: Michael Stros, et al.
Published: (2020-09-01) -
Qualitative Valuation Analysis in Emerging Biotechnology Companies: Comparison Study of Two Biotechnology Companies in Taiwan
by: Isin Demir Lin, et al.
Published: (2019) -
The study of Taiwan''s biotechnology and pharmaceutical competitive advantage.
by: Yon-yu Lin, et al.
Published: (2004)